Hydrogenology
Source-linked study record

Effects of hydrogen-rich water prepared by alternating-current-electrolysis on antioxidant activity, DNA oxidative injuries, and diabetes-related markers

Asada R, Tazawa K, Sato S, Miwa N. · Medical Gas Research. 2020;10(3):114–121.

HumanH₂-rich waterPublished 2020Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Human

Population or model

Japanese adults with fasting blood glucose above 6.1 mmol/L and below approximately 7.8 mmol/L who were not taking glucose-lowering medication.

Intervention and dose

Participants drank 1,500 mL/day of freshly prepared AC-electrolyzed H₂-rich water for eight weeks. · Dissolved H₂ reached 1.55 mg/L after 30 minutes of AC electrolysis; the same preparation had pH 7.7–7.8, dissolved O₂ 14.6 mg/L and ORP −270 mV.

Duration

Eight weeks, with measurements at baseline, four weeks and eight weeks.

Reported result

Urinary 8-OHdG decreased at eight weeks (P=0.028) and fructosamine at four weeks (P=0.008). The 8-OHdG formation-rate change, 1,5-AG changes and eight-week HbA1c change were not statistically significant. The article calls the fasting-glucose change significant while reporting P=0.051, which is above the conventional P<0.05 threshold. No treatment-related abnormality was reported among completers.

Main limitation

Very small uncontrolled open-label study, one dropout, selected borderline-hyperglycemic participants, multiple outcomes and no control for diet, exercise or regression to the mean. The apparatus used a patented commercial method. A Japanese anti-aging research grant partly funded the study; authors declared no conflicts.

Evidence and classification

What kind of evidence is this?

Evidence type

Human

Reported design

Open-label single-arm clinical study accompanied by laboratory characterization of the prepared water

Research topic

Metabolic and lipid health

Administration form

H₂-rich water

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Japanese adults with fasting blood glucose above 6.1 mmol/L and below approximately 7.8 mmol/L who were not taking glucose-lowering medication.

Sample

Ten enrolled; one withdrew for clinical reasons and nine completed (five men, four women; age 39–63 years).

Duration

Eight weeks, with measurements at baseline, four weeks and eight weeks.

Intervention

Participants drank 1,500 mL/day of freshly prepared AC-electrolyzed H₂-rich water for eight weeks.

Hydrogen form

H₂ dissolved in drinking water — not Brown's gas and not inhalation.

Dose or H₂ specification

Dissolved H₂ reached 1.55 mg/L after 30 minutes of AC electrolysis; the same preparation had pH 7.7–7.8, dissolved O₂ 14.6 mg/L and ORP −270 mV.

Comparator

Baseline values in the same participants; there was no randomized, blinded or concurrent control group.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Urinary 8-OHdG measures, fasting glucose, HbA1c, fructosamine, 1,5-anhydro-D-glucitol, routine blood/urine tests and adverse findings.

Reported result

Urinary 8-OHdG decreased at eight weeks (P=0.028) and fructosamine at four weeks (P=0.008). The 8-OHdG formation-rate change, 1,5-AG changes and eight-week HbA1c change were not statistically significant. The article calls the fasting-glucose change significant while reporting P=0.051, which is above the conventional P<0.05 threshold. No treatment-related abnormality was reported among completers.

Extraction completeness

The complete free PMC article, methods, figures and disclosure section were checked for water preparation/concentration, participant flow, time points, positive and null findings, the internally problematic P=0.051 wording, safety, funding and conflicts.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Very small uncontrolled open-label study, one dropout, selected borderline-hyperglycemic participants, multiple outcomes and no control for diet, exercise or regression to the mean. The apparatus used a patented commercial method. A Japanese anti-aging research grant partly funded the study; authors declared no conflicts.

Applies directly to

Exploratory biomarker observations in nine adults; it does not establish prevention or treatment of diabetes.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 33004708 · DOI: 10.4103/2045-9912.296041

Publisher access

Free full article in PubMed Central.

Extraction basis

Complete PMC article and PubMed metadata; full-text extraction checked 9 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.